Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery
In this study, we performed high-throughput target metabolic analysis on 44 serum samples, including 22 from AIS patients and 22 from healthy controls. Multiple-reaction monitoring analysis of 180 common metabolites revealed a total of 29 metabolites that changed significantly (VIP > 1, p < 0.05). Multivariate statistical analysis unraveled a striking separation between AIS patients and healthy controls. Comparing the AIS group with the control group, the contents of argininosuccinic acid, beta-D-glucosamine, glycerophosphocholine, L-abrine, and L-pipecolic acid were remarkably downregulated in AIS patients. Twenty-nine out of 112 detected metabolites enriched in disturbed metabolic pathways, including aminoacyl-tRNA biosynthesis, glycerophospholipid metabolism, lysine degradation, phenylalanine, tyrosine, and tryptophan biosynthesis metabolic pathways. Collectively, these results will provide a sensitive, feasible diagnostic prospect for AIS patients.PMID:35789984 | DOI:10.1007/s12010-022-04024-1
Source: Applied Biochemistry and Biotechnology - Category: Biochemistry Authors: Biao Qi Yanyu Zhang Bing Xu Yuhao Zhang Guoqiang Fei Ling Lin Qiuping Li Source Type: research
More News: Biochemistry | Biotechnology | Brain | Glucosamine | Ischemic Stroke | Neurology | Nutrition | Statistics | Stroke | Study